###begin article-title 0
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
###end article-title 0
###begin p 1
Conceived and designed the experiments: JMD. Performed the experiments: FG CS AL EP JCB. Analyzed the data: FG CS IR JCB BG JMD. Contributed reagents/materials/analysis tools: DJS EMR MLA. Wrote the paper: FG JMD.
###end p 1
###begin p 2
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 599 605 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 1020 1026 1020 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 303 318 <span type="species:ncbi:10090">transgenic mice</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 989 1004 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1166 1170 <span type="species:ncbi:10090">mice</span>
Individuals with partial HSA21 trisomies and mice with partial MMU16 trisomies containing an extra copy of the DYRK1A gene present various alterations in brain morphogenesis. They present also learning impairments modeling those encountered in Down syndrome. Previous MRI and histological analyses of a transgenic mice generated using a human YAC construct that contains five genes including DYRK1A reveal that DYRK1A is involved, during development, in the control of brain volume and cell density of specific brain regions. Gene dosage correction induces a rescue of the brain volume alterations. DYRK1A is also involved in the control of synaptic plasticity and memory consolidation. Increased gene dosage results in brain morphogenesis defects, low BDNF levels and mnemonic deficits in these mice. Epigallocatechin gallate (EGCG) - a member of a natural polyphenols family, found in great amount in green tea leaves - is a specific and safe DYRK1A inhibitor. We maintained control and transgenic mice overexpressing DYRK1A on two different polyphenol-based diets, from gestation to adulthood. The major features of the transgenic phenotype were rescued in these mice.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Delabar1">[1]</xref>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Korenberg1">[2]</xref>
###xml 720 723 720 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Ronan1">[3]</xref>
###xml 783 786 783 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Guimera1">[4]</xref>
###xml 852 855 852 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Tejedor1">[5]</xref>
###xml 1053 1056 1053 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Lochhead1">[6]</xref>
###xml 1226 1229 1226 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Woods1">[7]</xref>
###xml 1231 1234 1231 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Murakami1">[8]</xref>
###xml 1236 1239 1236 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Woods2">[9]</xref>
###xml 1577 1581 1577 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Dowjat1">[10]</xref>
###xml 477 485 <span type="species:ncbi:9606">children</span>
Phenotype mapping, based upon comparisons between genotypes and phenotypes of partial trisomy 21, has revealed that some regions of HSA21 may contain genes involved in specific phenotypes characteristic of Down syndrome (DS) including mental retardation. One such region, DCR-1 [1], [2], contains 19 genes, one of which - DYRK1A [Dual specificity Tyrosine(Y) Regulated Kinase 1A] - is closely associated with Down syndrome phenotypes. A recent study describes a mother and two children presenting a facial phenotype characteristic of DS and with moderate mental retardation. These individuals carry a small duplication of 10 genes including DYRK1A, consistent with a role for DYRK1A as a candidate gene in Down syndrome [3]. DYRK1A is a mammalian ortholog of minibrain in drosophila [4], a gene which is essential for normal postembryonic neurogenesis [5]; as its name implies, the DYRK1A enzyme has dual substrate specificities: autophosphorylation for self activation takes place on the tyrosine-321 residue in the active loop of the catalytic domain [6] and target protein phosphorylation occurs on serine/threonine residues. Many targets have been identified in vitro including FKHR, dynamin1, amphiphysin and tau protein [7], [8], [9]. These findings suggest that DYRK1A is a major player in both cell cycle regulation and synaptic plasticity. DYRK1A levels in the brains of DS subjects with free trisomy were found approximately 1.5-fold higher than those in normal subjects indicating that this protein is overproduced in a gene dosage-dependent manner in Down syndrome [10].
###end p 4
###begin p 5
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Baxter1">[11]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Aldridge1">[12]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Reeves1">[13]</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Escorihuela1">[14]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Fernandez1">[15]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Olson1">[16]</xref>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Dahmane1">[17]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Hattori1">[18]</xref>
###xml 1213 1217 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Smith1">[19]</xref>
###xml 1219 1223 1219 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Branchi1">[20]</xref>
###xml 1225 1229 1225 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Chabert1">[21]</xref>
###xml 1495 1499 1495 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Ahn1">[22]</xref>
###xml 1966 1970 1966 1970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Sebri1">[23]</xref>
###xml 2441 2445 2441 2445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Fotaki1">[24]</xref>
###xml 2651 2655 2651 2655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-BenavidesPiccione1">[25]</xref>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 397 401 <span type="species:ncbi:10090">Mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
###xml 887 902 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 936 941 <span type="species:ncbi:4932">yeast</span>
###xml 1028 1033 <span type="species:ncbi:9606">human</span>
###xml 1141 1147 <span type="species:ncbi:10090">murine</span>
###xml 1248 1263 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1463 1467 <span type="species:ncbi:10090">mice</span>
###xml 1485 1490 <span type="species:ncbi:9606">human</span>
###xml 1514 1519 <span type="species:ncbi:9606">human</span>
###xml 1538 1544 <span type="species:ncbi:10090">murine</span>
###xml 1569 1575 <span type="species:ncbi:10090">murine</span>
###xml 1782 1797 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1816 1820 <span type="species:ncbi:10090">mice</span>
###xml 2154 2169 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2188 2192 <span type="species:ncbi:10090">mice</span>
###xml 2498 2502 <span type="species:ncbi:10090">mice</span>
Murine models with partial MMU16 trisomies such as Ts65Dn, Ts1Cje or human HSA21 - all carrying extra copies of several genes, including the DYRK1A gene - have been generated. These models present morphogenesis defects in the cranium and brain [11], [12], together with learning and memory defects [13], detectable in such paradigms as the Morris water maze [14] or object recognition [15] tests. Mice carrying a smaller duplication with 33 genes, encompassing the gene encoding DYRK1A, present brain alterations but do not display abnormal behavior in the Morris water maze. However, deletion of the same region in a model with partial MMU16 trisomy, Ts65Dn, corrects the cognitive deficits seen in the Ts65Dn mice [16]. These results strongly suggest that duplication of genes from this region is necessary to produce the learning impairment seen in the Ts65Dn model of Down syndrome. Transgenic mice have also been developed using a yeast artificial chromosome from this region (YAC 152F7). cDNA mapping experiments [17] and human genome sequencing [18] showed that YAC152F7 contains five genes: PIGP, TTC3, DSCR9, DSCR3 and DYRK1A. This murine model presents both brain abnormalities and learning impairments [19], [20], [21]. On the contrary, transgenic mice for the YAC 141G6 bearing extra copies of all genes included in YAC 152F7 except for DYRK1A did not display any brain or behavioural alterations. Similar phenotypic alterations have been obtained in mice transgenic for a human BAC [22] carrying only human DYRK1A and with a murine BAC clone carrying only murine Dyrk1a (data not shown). In a previous study, using regional MRI, we found that morphological alterations throughout the brain in the YAC tg152F7 were not uniform: the total brain volume was 14% greater in transgenic mice than in wild-type mice, with an effect 2,5 greater (25%/10%) in the ventral region (including the thalamic-hypothalamic region) than in the cortex (10% greater volume) [23]. Unbiased stereological cell counts of NeuN-positive neurons revealed a greater cell density in the thalamic-hypothalamic area and a lower cell density in the somatosensory cortex in transgenic mice than in wild-type mice. These results indicate that the phenotypic effects of overexpressing the DYRK1A gene in the brain differ in a region-specific manner. These morphological alterations are inverse with those described in a model with heterozygous deletion of Dyrk1a [24] (including a smaller brain volume than in wild-type mice, particularly in the ventral region). The invalidated heterozygous model also displays learning impairments and an altered pyramidal cell phenotype [25].
###end p 5
###begin p 6
###xml 312 316 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Bain1">[26]</xref>
###xml 467 471 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Adayev1">[27]</xref>
###xml 512 516 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Lin1">[28]</xref>
###xml 543 547 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Chu1">[29]</xref>
###xml 928 932 924 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Choi1">[30]</xref>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
We investigated the possibility of correcting these phenotypes through modulation of DYRK1A activity. Bain and colleagues described the properties of 30 inhibitors, tested with 25 different kinases: one of the most specific inhibitors of DYRK1A was epigallocatechin gallate, with an apparent IC50 of 0.33 microM [26]. DYRK1A inhibition by EGCG was also demonstrated in NIH3T3 cells and a mutation analysis indicated a mechanism involving a non competitive inhibition [27]. EGCG can cross the blood-brain barrier [28] and the placental barrier [29]. EGCG is the major catechin in green tea leaves (40 to 50% of the total catechins amount). Indeed, feeding a green tea drink to mice (usually drinking 3-5 ml/day) is equivalent to administering 0.6 mg/day pure EGCG, which is effective in the treatment of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease (MPTP), through its effects on dopaminergic neurons [30].
###end p 6
###begin p 7
###xml 14 18 <span type="species:ncbi:10090">mice</span>
We maintained mice on two polyphenol-based diets from gestation to adulthood. Using the phenotypic tools that we have previously designed we compared the effects of these diets on batches of control and transgenic animals.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Link between the Dyrk1a gene copy number and the brain phenotypes
###end title 9
###begin p 10
###xml 163 169 163 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g001">Fig 1A</xref>
###xml 301 307 301 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g001">fig 1B</xref>
###xml 310 319 310 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g001">Figure 1C</xref>
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
We generated double transgenic mice by crossing YACtg152F7 with Dyrk1a (+/-) mice. Resultant double transgenic mice had normal levels of DYRK1A mRNA in the brain (Fig 1A) and a corrected body weight (data not shown); MRI analyses revealed a corrected brain volume and a corrected regional morphology (fig 1B). Figure 1C shows a linear regression analysis of the relationship between brain volume and Dyrk1a gene copy number.
###end p 10
###begin title 11
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
Phenotypic correction by genotype correction of DYRK1A copy number.
###end title 11
###begin p 12
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DYRK1A</italic>
Wild type (WT), YACtg152F7 transgenic (TG), dyrk1a (+/-) (HT) and double transgenics (TGxHT) generated by three different crossings. A: brain DYRK1A mRNA levels determined by quantitative PCR; B: in vivo MRI assessment of total brain volume (mm3); ** for p<0.01. (Mann-Whitney-Wilcoxon test; statistical significance considered to be p<0.05); C: linear regression analysis of brain volume and DYRK1A gene dosage. (R2 = 0.977).
###end p 12
###begin title 13
GTP (Green tea polyphenols) diet and brain morphogenesis
###end title 13
###begin p 14
Thus brain volume is regulated by DYRK1A gene copy number. Indeed inhibiting the activity of DYRK1A may counteract the phenotypic effects of its overexpression.
###end p 14
###begin p 15
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Yang1">[31]</xref>
###xml 56 60 <span type="species:ncbi:10090">Mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 463 472 <span type="species:ncbi:4442">black tea</span>
We used a green tea infusion, which was prepared daily. Mice were maintained on this diet from gestation (started during initial mating period) and through adulthood, until they were killed for examination. The study included four groups of mice: wild-type (wt) and transgenic (tg), fed with water or with green tea. The active compounds in green tea infusions are thought to be predominantly polyphenols and caffeine, which is less abundant in green tea than in black tea [31].
###end p 15
###begin p 16
###xml 208 220 208 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g002">fig 2A and B</xref>
The amount of the protein dyrk1a in samples prepared from dissected hypothalamus-thalamus region was assessed by western blot analysis for the four groups of animals: this amount is not modified by the diet.(fig 2A and B)
###end p 16
###begin title 17
Average DYRK1A protein levels in thalamus-hypothalamus for each genotype-treatment group.
###end title 17
###begin p 18
A: western blot assessment of dyrk1a and actin levels; B: average Dyrk1a protein levels for wild type (WT, n = 6), YACtg152F7 transgenic (TG, n = 6) water-fed (H2O) and in wild type (WT, n = 3), YACtg152F7 transgenic (TG, n = 7) green tea-fed (GTP). ** for p<0.01.
###end p 18
###begin p 19
###xml 95 100 95 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g003">fig 3</xref>
###xml 832 839 832 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004606.s001">Data S1</xref>
###xml 115 130 <span type="species:ncbi:10090">transgenic mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
We assessed total brain volume using in vivo MRI and determined brain weight after dissection (fig 3). Brains from transgenic mice fed with green tea were 7.1% heavier, and had 7.5% greater volume, than wild-type mice green tea fed; the transgenic fed water had 13.2% heavier brains, with 15% greater volume than wt water fed. The regional volume of the thalamic-hypothalamic region was 24.4% greater in water-fed YACtg152F7 mice as compared to WT, and only 9% greater in green tea-fed YACtg152F7 mice as compared to WT. There are small but significant differences in brain weight and volume of the thalamus-hypothalamus region between water-fed and green tea-fed wild-type mice. Two-way ANOVA revealed significant effects of genotype and treatment and an interaction between treatment and genotype effect (supplementary table 1 in Data S1).
###end p 19
###begin title 20
Effect of GTP treatment on DYRK1A-induced brain alterations.
###end title 20
###begin p 21
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 449 450 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
A: weight of total brain (mg) in wild type (WT, n = 26), YACtg152F7 (TG, n = 13) water-fed (H2O) and in wild type (WT, n = 13), YACtg152F7 transgenic (TG, n = 18) green tea-fed GTP; B: in vivo MRI assessment of total brain volume (mm3) in wild type (n = 10) and YACtg152F7 transgenic (n = 10) water-fed (H2O) and in wild type (n = 9) and YACtg152F7 transgenic (n = 11) green tea-fed GTP; C: in vivo MRI assessment of hypothalamus-thalamus volume (mm3) in wild type (n = 6) and YACtg152F7 transgenic (n = 6) water-fed (H2O) and in wild type (n = 5) and YACtg152F7 transgenic (n = 7) green tea-fed (GTP). (Details of the MRI experiments in supp. data). ** for p<0.01; * for p<0.05.
###end p 21
###begin title 22
GTP diet and learning deficit
###end title 22
###begin p 23
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-ODoherty1">[32]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Bozon1">[33]</xref>
###xml 708 714 708 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g004">fig 4A</xref>
###xml 1967 1973 1967 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g004">fig 4B</xref>
###xml 2524 2530 2524 2530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g004">fig 4C</xref>
###xml 40 46 <span type="species:ncbi:10090">murine</span>
###xml 732 737 <span type="species:ncbi:10090">mouse</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
###xml 1141 1146 <span type="species:ncbi:10090">mouse</span>
###xml 1442 1457 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1478 1482 <span type="species:ncbi:10090">mice</span>
###xml 1511 1515 <span type="species:ncbi:10090">mice</span>
###xml 1536 1540 <span type="species:ncbi:10090">mice</span>
###xml 1883 1898 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1961 1965 <span type="species:ncbi:10090">mice</span>
###xml 2239 2243 <span type="species:ncbi:10090">mice</span>
###xml 2316 2331 <span type="species:ncbi:10090">transgenic mice</span>
A learning deficit was also observed in murine models overexpressing the DYRK1A gene, using the Morris water maze with direct and reverse platform paradigms. These defects may indicate a long-term memory deficit. We used two paradigms, spontaneous alternation in the Y-maze and object recognition, to assess the effects on short-term and long-term memory, respectively [32], [33]. The Y-maze consists of three arms, each of which the animal is free to visit. The rate of spontaneous alternation (visiting each arm in turn) was greater than 50% for each of the four groups. Similar findings were obtained for both of two test sessions (number of alternations/total number of possible alternations x100 (AS1), fig 4A), indicating all mouse groups had similar levels of working memory. Additionally, the number of entries did not differ between the first and the second halves of the first session, between the first and second sessions and between groups of mice. This demonstrated both short-term habituation and long-term habituation of the mice, neither of which were affected by treatment or genotype. In the object recognition test, each mouse is placed individually in an open-field setting, in which one object is placed at the left-hand side and a second object at the right-hand side. The test comprises five daily sessions. After the training sessions one object is substituted for a novel object. Exploration time was lower with the transgenic mice than with wild-type mice, and lower with GTP-treated mice than with water-fed mice during both the acquisition and retention sessions. Wild-type animals showed a clear long-term memory acquisition during the retention session. By contrast, the memory index 100x(N-F/N+F) was close to zero for water-fed transgenic animals: these animals were unable to recognize object novelty in the object recognition task. The GTP-treated transgenic mice showed discrimination indices equivalent to that of wild type mice (fig 4B). The main constituents of green tea infusion are catechins and caffeine. We used purified polyphenols from green tea (polyphenon 60; see composition in sup Table III) to assess the effect of a purified compound. This second experiment incorporated three groups of mice: water-fed controls, polyphenon-treated controls and polyphenon-treated transgenic mice. Each of the three groups had similar exploration times in the novel object recognition paradigm and recognized the novel object, demonstrating similar object novelty discrimination behavior (fig 4C).
###end p 23
###begin title 24
Effect of GTP treatment on short- and long-term memory.
###end title 24
###begin p 25
###xml 651 652 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In wild type (WT, n = 10) and YACtg152F7 transgenic (TG, n = 10) water-fed (H2O) and in wild type (WT, n = 10) and YACtg152F7 transgenic (TG, n = 10) green tea-fed (GTP, n = 10). A: Spontaneous alternation test with two sessions of ten minutes each separated by 24 h: number of alternations/total number of possible alternations x100 (AS1). B: Object recognition test: difference in exploration time between the new and familiar objects, in percentage of total time spent exploring the two objects; 100x(N-F/N+F). ** for p<0.01, * for p<0.05. according to Wilcoxon test results (two-way ANOVA in supplementary data). C: Object recognition test on WT H2O-fed (n = 10), WT polyphenon-fed (n = 10) and TG polyphenon-fed (n = 6) (no significant differences between the three groups).
###end p 25
###begin title 26
Effect of GTP diet on markers of synaptic plasticity
###end title 26
###begin p 27
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Hall1">[34]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Heldt1">[35]</xref>
###xml 534 540 534 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g005">Fig 5A</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Barco1">[36]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Branchi1">[20]</xref>
###xml 950 956 950 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g005">Fig 5B</xref>
###xml 1145 1151 1145 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g005">Fig 5C</xref>
###xml 273 278 <span type="species:ncbi:9606">human</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 733 748 <span type="species:ncbi:10090">transgenic mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 900 904 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
The ability of animals to learn and remember may be encoded at the synaptic level: synaptic plasticity has been linked to various factors including levels of the neurotrophic factor, BDNF [34], [35]. We used quantitative RT-PCR to measure BDNF mRNA levels in hippocampi of human fetal brains from individuals with trisomy 21 and from age-matched diploid individuals (19-21 weeks) to determine potential BDNF deficiency in trisomy 21 patients. BDNF mRNA levels were 50% lower in these patients than in age-matched diploid individuals (Fig 5A). BDNF transcription is regulated by CREB [36]. We have previously found low levels pCREB in the brains of YACtg152F7 mice [20]. In this study, we compared BDNF mRNA levels in hippocampi from transgenic mice with those from water-fed wild-type mice and BDNF mRNA levels of GTP-fed tg with wt mice. Tg mice had a lower level of BDNF in the hippocampus than wt mice; this defect was corrected by GTP treatment (Fig 5B). We also found that mRNA levels for the BDNF plasma membrane receptor, TRKB, were significantly lower in YACtg152F7 mice than in wt mice. This defect was also corrected by GTP treatment (Fig 5C).
###end p 27
###begin title 28
Effect of GTP treatment on BDNF and TRKB mRNA levels.
###end title 28
###begin p 29
###xml 61 66 <span type="species:ncbi:9606">human</span>
mRNA levels determined by quantitative PCR. A: BDNF in fetal human hippocampus (EU: normal karyotype (n = 4) and T21: trisomy 21 (n = 5); B: BDNF in adult hippocampus from wild type (WT; n = 6), YACtg152F7 transgenic (TG; n = 10), water-fed (H2O) WT (n = 8), TG (n = 3), green tea-fed (GTP); C: TRKB in adult hippocampus from wild type (WT; n = 4), YACtg152F7 transgenic (TG; n = 18), water-fed (H2O) WT (n = 4), TG (n = 4) green tea-fed (GTP). ** for p<0.01; * for p<0.05.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 547 553 547 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004606-g001">Fig 1C</xref>
###xml 1801 1805 1801 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-VanPraag1">[37]</xref>
###xml 2594 2597 2594 2597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Murakami1">[8]</xref>
###xml 3036 3040 3036 3040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Siarey1">[38]</xref>
###xml 3042 3046 3042 3046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Siarey2">[39]</xref>
###xml 3048 3052 3048 3052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Kleschevnikov1">[40]</xref>
###xml 3137 3141 3137 3141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Xie1">[41]</xref>
###xml 3593 3597 3593 3597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Tanaka1">[42]</xref>
###xml 3700 3704 3700 3704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Olofsdotter1">[43]</xref>
###xml 4053 4057 4053 4057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Fernandez1">[15]</xref>
###xml 4196 4200 4196 4200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Lee1">[44]</xref>
###xml 4224 4228 4224 4228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Chyu1">[45]</xref>
###xml 4303 4307 4303 4307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-RezaiZadeh1">[46]</xref>
###xml 164 170 <span type="species:ncbi:10090">murine</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 1481 1496 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1614 1618 <span type="species:ncbi:10090">mice</span>
###xml 1897 1901 <span type="species:ncbi:10090">mice</span>
###xml 2963 2969 <span type="species:ncbi:10090">murine</span>
###xml 3114 3118 <span type="species:ncbi:10090">mice</span>
###xml 4911 4919 <span type="species:ncbi:9606">patients</span>
In this study we have shown that modulation of the DYRK1A gene copy number can correct brain morphogenesis alterations. It is possible to compensate the deficit in murine Dyrk1a heterozygote by the addition of one copy of human DYRK1A; the correction operates also on the phenotypes seen in the YACtg152F7 model and induced by the overexpression. These results established Dyrk1a as a key player in control of brain development and brain morphogenesis: the brain volume, as shown by MRI experiments is strongly related to Dyrk1a gene copy number (Fig 1C). We also demonstrated that chronic administration of polyphenols from green tea can have a similar, although less efficient than normalizing the gene copy number, corrective effect on brain alterations indicating that the diet is bringing the level of active DYRK1A to a value between the values produced in the transgenic and the wild type situations. The effect of the polyphenols is also visible when comparing water fed and green tea fed wild type animals: the diet induces a significant reduction of brain weight and thalamus-hypothalamus volume suggesting that the diet induced reduction of active Dyrk1a is equivalent to a genic content below 2 copies. Polyphenol treatment had no effect on the results to the spontaneous alternation paradigm: transgenic animals do not show any impairment for this task and behave similarly to the control animals. Using a novel object recognition paradigm to assess long term memory, transgenic mice with three copies of DYRK1A were clearly impaired: polyphenol treatment ameliorates cognitive deficits in tgYAC152F7 mice. Other groups have shown an effect of polyphenols on brain functions: in a study designed to determine whether cognition could be influenced by a flavanol-rich diet, Van Praag et al [37] found that memory, hippocampal vascularisation and neuronal spine density were enhanced in mice fed a (-)epicatechin-containing diet compared with controls. The polyphenol treatment does not modify the amount of DYRK1A protein. Our results suggest either a direct effect of EGCG on the activity of DYRK1A or an indirect effect, acting via a downstream target in the DYRK1A pathway. DYRK1A phosphorylation of endocytic proteins has been observed in cell cultures: this phosphorylation modifies the interactions of dynamin 1, synaptojanin 1 and amphiphysin 1 with other members of the endocytic accessory proteins and potentially regulates the assembly of protein complexes. Additionally, EGCG treatment in HEK 293 cells results in decreased phosphorylation of amphiphysin, a DYRK1A target [8]. Modulation of these trafficking proteins is generally thought to influence synaptic plasticity. LTP and its opposing process, long-term depression, are widely considered the major cellular mechanisms that underlie learning and memory. LTP was reduced and LTD was augmented in comparison to diploid controls in the isolated hippocampus of Ts65Dn and Ts1Cje, two DS murine models carrying a partial trisomy 16 encompassing the DYRK1A gene [38], [39], [40]. LTP levels can be rescued in hippocampal slices from Ts65Dn mice by EGCG treatment [41]. This is consistent with our observations of long-term memory impairment rescue. These effects may be due to EGCG action on DYRK1A resulting in modulation of the endocytic apparatus and/or modulation of BDNF-related pathways. BDNF is one of the neurotrophins involved in the regulation of neuron survival and differentiation; it has also acute effects on synaptic transmission. It has been proposed that it acts as a modulator of GABAergic inhibition [42]. In hippocampal slices synaptic inhibition was enhanced by reduced BDNF expression in bdnf+/- animals [43]. Further experimentation will be needed to elucidate effects of timing of treatment on the various phenotypic outcomes. Although correction of morphogenesis defects may require an early treatment, treatment during adulthood may result in improvement of cognition performance; indeed, this was recently demonstrated using GABAa receptor antagonists [15]. However it should be also mentioned the EGCG is a potent antioxidant and a free radical scavenger and has protective effects in ischemia [44] and in atherosclerosis [45]. It can decrease the amyloidosis in the brain by acting on APP processing [46]. Therefore other EGCG targets may explain the observed rescue of phenotypes that are primarily caused by the overexpression of Dyrk1a. Nevertheless our results suggest a central role for Dyrk1a in CNS functioning and highlight a potential clinical benefit of DYRK1A inhibitors, particularly of natural polyphenol extracts; these extracts are already used as dietary supplements for the treatment of other disorders and have been shown to be well tolerated at doses similar to those used in the present study. Such treatment may potentially be used to improve the cognitive performances of Down syndrome patients.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
Animal housing, genotyping and treatment
###end title 33
###begin p 34
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Smith1">[19]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Fotaki1">[24]</xref>
###xml 965 969 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Branchi1">[20]</xref>
###xml 971 975 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Sebri1">[23]</xref>
###xml 1162 1166 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004606-Choi1">[30]</xref>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 431 435 <span type="species:ncbi:10090">Mice</span>
###xml 921 925 <span type="species:ncbi:10090">Mice</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
Transgenic mice were generated on an FVB inbred background [19]. Line 12 contains one copy of YAC152F7. The FVB background that was used for micro-injection of the transgenic fragments carries a recessive mutation (rd) inducing retinal degeneration. To avoid an effect of rd on visual cues, we used F1 male offspring from C57BL/6J females and transgenic FVB males for the behavioral experiments and corresponding mRNA experiments. Mice with heterozygous deletion of Dyrk1a [24] were bred on a Swiss background and transgenic FVB males (YACtg152F7) were crossed with Dyrk1a (+/-) females to generate offspring with the four different genotypes. All animals were bred under SPF conditions and were treated in compliance with animal welfare policies from the Ministry of Agriculture (law 87848). JMD has the habilitation 75-369 for experiences on vertebrates and these experiments have been approved by the CREEA Ndegrees4. Mice were genotyped as previously described [20], [23]. Treatment was prepared daily. In the first set of experiments, mice were fed green tea ad libitum (1 g in 100 ml water for 5 min at 100degreesC), corresponding to 0.6-1 mg EGCG per day [30]; in the second set of experiments, mice were given a solution of polyphenon 60 (0.8 g/l, Sigma), equivalent to 1.2 mg per day.
###end p 34
###begin title 35
Quantitative PCR experiments
###end title 35
###begin p 36
###xml 188 195 188 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004606.s001">Data S1</xref>
mRNA was isolated (Microfastrack, Invitrogen) and reverse transcribed (Ambion), and qRT-PCR (Light cycler, Roche) was performed with primer sequences described in supplementary table 2 in Data S1.
###end p 36
###begin title 37
Protein extraction and western blotting
###end title 37
###begin p 38
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 1217 1228 <span type="species:ncbi:3704">horseradish</span>
###xml 1276 1281 <span type="species:ncbi:10090">mouse</span>
Adult mice (3 months old) were sacrificed by decapitation. Brains were removed and dissected on ice to separate the cortex, hippocampus and the thalamus/hypothalamus before being frozen in liquid nitrogen and stored at -80degreesC. Individual thalamus/hypothalamus were homogenized in NP-40 modified lysis buffer [20 mM Tris-HCl (pH 7.4); 140 mM NaCl; 10% glycerol; 1% NP-40; 2 mM EDTA] containing proteases inhibitors (1 mM Pefa-Bloc; 2 microg/ml Aprotinin, leupeptin and pepstatine; 5 microg/ml E64) and phophatase inhibitors (2 mM NaF; 1 mM Na3VO4 and PhosSTOP phosphatase inhibitors cocktail). Protein concentration was determined using the Bio Rad Bradford protein assay following the manufacturer's instructions. For western blotting, equal amounts of total proteins (30-50 microg) were subjected to SDS-PAGE electrophoresis and transferred into nitrocellulose membranes. The latter were blocked with TBS (Tris buffered saline pH 7.5)-Tween 0,1% containing 5% of non-fat dried milk and incubated with the Dyrk1A antibody (Abnova, diluted 1:1000 in the blocking buffer) at 4degreesC overnight. Excess of primary antibody was removed by rinsing with TBS-T, followed by 1 h incubation with the species-appropriate horseradish peroxidase-conjugated secondary antibody (Anti-mouse Ig diluted 1:40000 in the blocking solution) at room temperature. Immunoblots were subsequently probed with anti-ss actin antibody (Sigma, diluted 1 :4000) as loading control. Signals were revealed by enhanced chemiluminescence with the LAS300 Image Reader and results analyzed with science Lab 2005 -MultiGauge software (Life science Fujufilm).
###end p 38
###begin title 39
MRI experiments
###end title 39
###begin p 40
###xml 274 281 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004606.s001">Data S1</xref>
We performed in vivo MRI studies on animals from three litters, using a horizontal 7T magnet connected to an INOVA console (Varian, CA) and equipped with 120 mT/m gradient coils and home-built 1H coils. Experimental conditions are given in the supplementary methods section Data S1. Brain structure volumes were estimated, using a visual guide visible on each image set. MRI analysis protocols were established and carried out independently by two investigators. The same analysis was performed twice, once with each of two software packages - WINMRI (Bruker) and AMIRA, (TGS Inc., San Diego, CA) - and by each investigator, to evaluate the reproducibility of volume measurements. Each 2D coronal data set consisted of 41 images. As brain volume depends on age and transgenic state, the number of slices taken was not constant and was therefore not used to delimit the brain. In scans taken between the appearance of the cerebellum and the disappearance of the olfactory bulbs, brain volumes were extracted by manually outlining regions of interest and multiplying by slice thickness (0.5 mm).
###end p 40
###begin title 41
Y alternation
###end title 41
###begin p 42
###xml 392 399 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004606.s001">Data S1</xref>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
Working memory, exploratory activity and short-term habituation were assessed using a spontaneous alternation task: the natural tendency of a mouse when placed in the Y-maze is to move from one arm of the maze to another. During the test, mice were placed at the centre of the maze and the sequence of entries into the three arms was noted over a period of 10 min. (see supp methods and supp Data S1).
###end p 42
###begin title 43
Novel Object recognition
###end title 43
###begin p 44
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004606.s001">Data S1</xref>
A novel object recognition test was used to assess the declarative memory (see supp methods in Data S1). The performance is measured on the whole retention session with: the time spent exploring the two objects (N+F), the difference of exploration time between the new object and the familiar object (N-F), the difference of exploration time between the new object and the familiar object in percent of the time spent exploring the two objects (%(N-F)/(N+F) = 100x(N-F)/(N+F)).
###end p 44
###begin p 45
Memory of the object is considered to be present for a group on a given period of time if animals spend more time in exploring the new object than the familiar one, i.e. if (N-F) and %(N-F)/(N+F) are higher than zero.
###end p 45
###begin title 46
Data analysis
###end title 46
###begin p 47
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004606.s001">Data S1</xref>
Data were analyzed using a Mann-Whitney-Wilcoxon test and statistical significance was recorded for p<0.05. A second analysis was used to assess the effects of treatment and genotype (two-way ANOVA results are presented in supplementary Data S1).
###end p 47
###begin title 48
Supporting Information
###end title 48
###begin p 49
(0.15 MB DOC)
###end p 49
###begin p 50
Click here for additional data file.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
Molecular mapping of twenty-four features of Down syndrome on chromosome 21.
###end article-title 52
###begin article-title 53
###xml 60 65 <span type="species:ncbi:9606">Human</span>
Report and abstracts of the Sixth International Workshop on Human Chromosome 21 Mapping. Cold Spring Harbor, New York, USA. May 6-8,1996.
###end article-title 53
###begin article-title 54
Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region.
###end article-title 54
###begin article-title 55
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 21 31 <span type="species:ncbi:7227">Drosophila</span>
A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region.
###end article-title 55
###begin article-title 56
###xml 81 91 <span type="species:ncbi:7227">Drosophila</span>
Minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila.
###end article-title 56
###begin article-title 57
Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.
###end article-title 57
###begin article-title 58
The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
###end article-title 58
###begin article-title 59
Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.
###end article-title 59
###begin article-title 60
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
###end article-title 60
###begin article-title 61
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
###end article-title 61
###begin article-title 62
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
###end article-title 62
###begin article-title 63
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
###end article-title 63
###begin article-title 64
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for Down syndrome exhibits learning and behaviour deficits.
###end article-title 64
###begin article-title 65
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome.
###end article-title 65
###begin article-title 66
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.
###end article-title 66
###begin article-title 67
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
###end article-title 67
###begin article-title 68
Transcriptional map of the 2.5-Mb CBR-ERG region of chromosome 21 involved in Down syndrome.
###end article-title 68
###begin article-title 69
###xml 20 25 <span type="species:ncbi:9606">human</span>
The DNA sequence of human chromosome 21.
###end article-title 69
###begin article-title 70
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome.
###end article-title 70
###begin article-title 71
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
###end article-title 71
###begin article-title 72
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Functional analysis of genes implicated in Down syndrome: 1. Cognitive abilities in mice transpolygenic for Down Syndrome Chromosomal Region-1 (DCR-1).
###end article-title 72
###begin article-title 73
###xml 11 26 <span type="species:ncbi:10090">transgenic mice</span>
DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects.
###end article-title 73
###begin article-title 74
Increased dosage of DYRK1A and brain volumetric alterations in a YAC model of partial trisomy 21.
###end article-title 74
###begin article-title 75
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.
###end article-title 75
###begin article-title 76
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse.
###end article-title 76
###begin article-title 77
The specificities of protein kinase inhibitors: an update.
###end article-title 77
###begin article-title 78
Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways.
###end article-title 78
###begin article-title 79
###xml 82 86 <span type="species:ncbi:10116">rats</span>
Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution.
###end article-title 79
###begin article-title 80
###xml 84 88 <span type="species:ncbi:10116">rats</span>
Uptake and distribution of catechins in fetal organs following in utero exposure in rats.
###end article-title 80
###begin article-title 81
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
###end article-title 81
###begin article-title 82
Effects of different steeping methods and storage on caffeine, catechins and gallic acid in bag tea infusions.
###end article-title 82
###begin article-title 83
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes.
###end article-title 83
###begin article-title 84
A requirement for the immediate early gene zif268 in reconsolidation of recognition memory after retrieval.
###end article-title 84
###begin article-title 85
Rapid and selective induction of BDNF expression in the hippocampus during contextual learning.
###end article-title 85
###begin article-title 86
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories.
###end article-title 86
###begin article-title 87
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture.
###end article-title 87
###begin article-title 88
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice.
###end article-title 88
###begin article-title 89
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome.
###end article-title 89
###begin article-title 90
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.
###end article-title 90
###begin article-title 91
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.
###end article-title 91
###begin article-title 92
Promotion of Neuronal Plasticity by (-)-Epigallocatechin-5 3-Gallate.
###end article-title 92
###begin article-title 93
###xml 86 89 <span type="species:ncbi:10116">rat</span>
Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus.
###end article-title 93
###begin article-title 94
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Increased synaptic inhibition in dentate gyrus of mice with reduced levels of endogenous brain-derived neurotrophic factor.
###end article-title 94
###begin article-title 95
Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils.
###end article-title 95
###begin article-title 96
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
###end article-title 96
###begin article-title 97
###xml 135 150 <span type="species:ncbi:10090">transgenic mice</span>
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.
###end article-title 97
###begin p 98
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 98
###begin p 99
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by EU grants: T21 targets(FP5) and AnEUploidy (FP6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 99

